Revvity, Inc last reported quarterly results on Nov 3, 2026, for Q3 FY2026 (the quarter ended Sep 27, 2026): revenue of $728.9 million (+4.3% year over year). It usually reports 16–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 12, 2027.
Results for Q4 FY2026, the quarter ending around Dec 27, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Jan 13, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 16–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 3, 2026
37 days after quarter end
From press release
|
Q3 FY2026
ended Sep 27, 2026
|
729
+4.3%
|
62
+33.5%
|
—
|
|
Aug 4, 2026
30 days after quarter end
|
Q2 FY2026
ended Jul 5, 2026
|
730
+1.3%
|
52
-3.9%
|
0.47
+2.2%
|
|
May 5, 2026
30 days after quarter end
|
Q1 FY2026
ended Apr 5, 2026
|
711
+7.0%
|
41
-3.6%
|
0.36
+2.9%
|
|
Jan 13, 2026
16 days after quarter end
|
Q4 FY2025
ended Dec 28, 2025
|
772
+5.9%
|
98
+3.9%
|
0.87
+11.4%
|
|
Oct 27, 2025
29 days after quarter end
|
Q3 FY2025
ended Sep 28, 2025
|
699
+2.2%
|
47
-50.6%
|
0.40
-48.1%
|
|
Jul 28, 2025
29 days after quarter end
|
Q2 FY2025
ended Jun 29, 2025
|
720
+4.1%
|
54
-2.6%
|
0.46
+2.2%
|
|
Apr 28, 2025
29 days after quarter end
|
Q1 FY2025
ended Mar 30, 2025
|
665
+2.3%
|
42
+62.4%
|
0.35
+66.7%
|
|
Jan 13, 2025
15 days after quarter end
|
Q4 FY2024
ended Dec 29, 2024
|
729
+4.8%
|
95
+20.5%
|
0.78
+22.4%
|
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- RVTY (NYSE)
- Fiscal year ends
- December 29
- Incorporated in
- MA
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 31791
- Former names
- PERKINELMER INC (until Apr 14, 2023); EG&G INC (until Jul 26, 1999)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.